Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry.

ABSTRACT:

Objective

To investigate evolving patterns in antithrombotic treatment in UK patients with newly diagnosed non-valvular atrial fibrillation (AF).

Design

Prospective, multicentre, international registry.

Setting

186 primary care practices in the UK.

Participants

3482 participants prospectively enrolled in four sequential cohorts (cohort 2 (C2) n=830, diagnosed September 2011 to April 2013; cohort 3 (C3) n=902, diagnosed April 2013 to June 2014; cohort 4 (C4) n=850, diagnosed July 2014 to June 2015; cohort 5 (C5) n=900, diagnosed June 2015 to July 2016). Participants had newly diagnosed non-valvular AF and at least one risk factor for stroke, were aged ≥18, and provided informed consent.

Main outcome measures

Antithrombotic treatment initiated at diagnosis

SUBMITTER: Apenteng PN 

PROVIDER: S-EPMC5781154 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature